BusinessDendritic Cell Vaccine Inhibits Tumor Progression in Preclinical Liver Cancer ModelBy Nasdaq OMXFeb 25, 2016, 5:16 PM UTC
BusinessPhase 1b Clinical Trial of BPZE1 Pertussis Vaccine Completes Enrollment of Randomized Study GroupsBy Nasdaq OMXFeb 19, 2016, 2:55 PM UTC
BusinessAchillion Initiates Phase 1 Study of ACH-4471, First Orally-Administered Small Molecule Complement Factor D InhibitorBy Nasdaq OMXFeb 11, 2016, 11:05 AM UTC
BusinessHuman Validation Data Supporting Saronic Biotechnology’s Lead Therapeutic SBI1997 Published in the Journal of ImmunotherapyBy Nasdaq OMXFeb 9, 2016, 4:11 PM UTC
BusinessAgile Therapeutics Announces Pricing of Its Public Offering of Common StockBy Nasdaq OMXJan 22, 2016, 2:17 PM UTC
BusinessSummit Therapeutics Receives Regulatory Approval to Initiate PhaseOut DMD, a Phase 2 Clinical Trial of SMT C1100 in Patients With DMDBy Nasdaq OMXJan 21, 2016, 12:00 PM UTC
BusinessFilament BioSolutions Announces Strategic Partnership With Ajinomoto to Develop a Portfolio of Evidence-Based Medical FoodsBy Nasdaq OMXJan 11, 2016, 2:33 PM UTC
BusinessOcera Appoints Dr. Stan Bukofzer as Chief Medical OfficerBy Nasdaq OMXJan 7, 2016, 9:05 PM UTC
